pDNA Intralesional Cancer Vaccine for Cutaneous Melanoma
Clinical trial NCT03655756 · COMPLETED
Trial details
- NCT number
- NCT03655756
- Sponsor
- TuHURA Biosciences, Inc.
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-05
- Primary completion
- 2020-07-10
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.